Director Bryan Cressey resigns; Select Medical awards 1.05M restricted shares to executives

SELECT MEDICAL HOLDINGS CORP

Director Bryan C. Cressey resigned effective Aug 2, 2023; no disagreement with company or board.
Compensation Committee granted 1,050,000 restricted shares to seven executives under 2020 Equity Plan.
David Chernow and Robert Ortenzio each received 250,000 shares; Rocco Ortenzio and Martin Jackson each 150,000.
Shares for Chernow, R. Ortenzio, Jackson, Tarvin vest equally over 3 years; Saich and Mullin vest on Aug 1, 2026.
Michael Tarvin received 100,000 shares; Saich and Mullin each 75,000 shares.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bryan C. Cressey

Director

SEM · SELECT MEDICAL HOLDINGS CORP

Effective: 2023-08-02
Filed: August 2, 2023, 7:59 PM ET

Bryan C. Cressey, a director of the Select Medical Holdings Corporation (the “Company”) and chairman of the Compensation Committee (the “Compensation Committee”) of the Company’s Board of Directors, notified the Company of his decision to resign as a director, effective August 2, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bryan C. Cressey resigned as Director at SELECT MEDICAL HOLDINGS CORP.

Action: resigned
Role: Director

Exact text from the filing

Bryan C. Cressey, a director of the Select Medical Holdings Corporation (the “Company”) and chairman of the Compensation Committee (the “Compensation Committee”) of the Company’s Board of Directors, notified the Company of his decision to resign as a director, effective August 2, 2023.

View on SEC.gov

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-086804

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.